StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) stock

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.25+0.24 (+5.85%)

Close on Nov 18, 2026Market cap $411.07MP/E –Yield –

Rezolute cash

Cash and short-term investments held at the end of each period.

Rezolute's cash was $90.00M at Sep 30, 2026. For fiscal 2026 it was $107.80M, down 35.8% from the year before. Over ten years it grew 38.8% a year on average. The highest annual figure on record is $167.86M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$107.80M-35.8%
FY2025Jun 30, 2025$167.86M+32.3%
FY2024Jun 30, 2024$126.87M+24.5%
FY2023Jun 30, 2023$101.90M-32.3%
FY2022Jun 30, 2022$150.41M+266.4%
FY2021Jun 30, 2021$41.05M+312.3%
FY2020Jun 30, 2020$9.96M-73.5%
FY2019Jun 30, 2019$37.60M+224.9%
FY2018Jun 30, 2018$11.57M+157.9%
FY2017Jun 30, 2017$4.49M+10.5%
FY2016Jun 30, 2016$4.06M-23.0%
FY2015Jun 30, 2015$5.28M-11.1%
FY2014Jun 30, 2014$5.93M+918558.5%
FY2011Dec 31, 2011$646+35.1%
FY2010Dec 31, 2010$478–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$90.00M-40.9%
Q4 FY2026CQ2 2026Jun 30, 2026$107.80M-35.8%
Q3 FY2026CQ1 2026Mar 31, 2026$120.27M+38.4%
Q2 FY2026CQ4 2025Dec 31, 2025$132.94M+37.7%
Q1 FY2026CQ3 2025Sep 30, 2025$152.19M+40.6%
Q4 FY2025CQ2 2025Jun 30, 2025$167.86M+32.3%
Q3 FY2025CQ1 2025Mar 31, 2025$86.89M+8.6%
Q2 FY2025CQ4 2024Dec 31, 2024$96.54M+4.3%
Q1 FY2025CQ3 2024Sep 30, 2024$108.27M+9.7%
Q4 FY2024CQ2 2024Jun 30, 2024$126.87M+24.5%
Q3 FY2024CQ1 2024Mar 31, 2024$80.02M-22.4%
Q2 FY2024CQ4 2023Dec 31, 2023$92.60M-36.9%
Q1 FY2024CQ3 2023Sep 30, 2023$98.73M-36.0%
Q4 FY2023CQ2 2023Jun 30, 2023$101.90M-32.3%
Q3 FY2023CQ1 2023Mar 31, 2023$103.06M+62.5%
Q2 FY2023CQ4 2022Dec 31, 2022$146.75M+78.1%
Q1 FY2023CQ3 2022Sep 30, 2022$154.32M+313.8%
Q4 FY2022CQ2 2022Jun 30, 2022$150.41M+266.4%
Q3 FY2022CQ1 2022Mar 31, 2022$63.42M+98.2%
Q2 FY2022CQ4 2021Dec 31, 2021$82.40M+119.2%
Q1 FY2022CQ3 2021Sep 30, 2021$37.29M+482.3%
Q4 FY2021CQ2 2021Jun 30, 2021$41.05M+312.3%
Q3 FY2021CQ1 2021Mar 31, 2021$31.99M+128.0%
Q2 FY2021CQ4 2020Dec 31, 2020$37.60M+106.8%
Q1 FY2021CQ3 2020Sep 30, 2020$6.40M-71.0%
Q4 FY2020CQ2 2020Jun 30, 2020$9.96M-73.5%
Q3 FY2020CQ1 2020Mar 31, 2020$14.03M+21.3%
Q2 FY2020CQ4 2019Dec 31, 2019$18.18M+23174.7%
Q1 FY2020CQ3 2019Sep 30, 2019$22.10M+2446.3%
Q4 FY2019CQ2 2019Jun 30, 2019$37.60M+836.3%
Q4 FY2018CQ2 2018Jun 30, 2018$11.57M+157.9%
Q3 FY2018CQ1 2018Mar 31, 2018$78.12K-98.2%
Q2 FY2018CQ4 2017Dec 31, 2017$868.07K-75.7%
Q1 FY2018CQ3 2017Sep 30, 2017$4.02M+19.3%
Q4 FY2017CQ2 2017Jun 30, 2017$4.49M+10.5%
Q3 FY2017CQ1 2017Mar 31, 2017$4.44M+154.1%
Q2 FY2017CQ4 2016Dec 31, 2016$3.57M–
Q1 FY2017CQ3 2016Sep 30, 2016$3.37M–
Q4 FY2016CQ2 2016Jun 30, 2016$4.06M–
Q3 FY2016CQ1 2016Mar 31, 2016$1.75M–

More Rezolute figures

See a number that looks wrong?